0001628280-19-009172.txt : 20190729 0001628280-19-009172.hdr.sgml : 20190729 20190729210134 ACCESSION NUMBER: 0001628280-19-009172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190729 FILED AS OF DATE: 20190729 DATE AS OF CHANGE: 20190729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cozzens Todd C CENTRAL INDEX KEY: 0001382487 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38993 FILM NUMBER: 19982990 MAIL ADDRESS: STREET 1: ONE FEDERAL STREET STREET 2: 25TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst, Inc. CENTRAL INDEX KEY: 0001636422 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 453337483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3165 E. MILLROCK, SUITE 400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 801-708-6800 MAIL ADDRESS: STREET 1: 3165 E. MILLROCK, SUITE 400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: HQC Holdings, Inc. DATE OF NAME CHANGE: 20150312 4 1 wf-form4_156444847869001.xml FORM 4 X0306 4 2019-07-29 0 0001636422 Health Catalyst, Inc. HCAT 0001382487 Cozzens Todd C C/O HEALTH CATALYST, INC. 3165 MILLROCK DRIVE, #400 SALT LAKE CITY UT 84121 1 0 0 0 Common Stock 2019-07-29 4 C 0 43967 0 A 134331 D Common Stock 2019-07-29 4 C 0 6344 0 A 140675 I By Matoaka, LLC Common Stock 2019-07-29 4 C 0 943484 0 A 1084159 I By Leerink Transformation Fund I, L. P. Series C Preferred Stock 2019-07-29 4 C 0 43967 0 D Common Stock 43967.0 0 D Series D Preferred Stock 2019-07-29 4 C 0 6344 0 D Common Stock 6344.0 0 D Series E Preferred Stock 2019-07-29 4 C 0 943484 0 D Common Stock 943484.0 0 D Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. The shares are held by Matoaka, LLC and the Reporting Person holds the voting and dispositive power over the shares. Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. The shares are held by Leerink Transformation Fund I, L.P. ("Leerink") and the Reporting Person is a co-founder and Managing Partner of Leerink and holds voting and dispositive power over the shares. /s/ Daniel Orenstein, as Attorney-in-Fact 2019-07-29